Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Traws Pharma, Inc. Director's Dealing 2025

Feb 10, 2025

35199_dirs_2025-02-10_cba2fbbb-ecd2-4c1f-ac17-6dc18283f2a4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Traws Pharma, Inc. (TRAW)
CIK: 0001130598
Period of Report: 2025-02-05

Reporting Person: Guerin Mark Patrick (Chief Financial Officer)

More from Traws Pharma, Inc.

Annual Report 2026
May 29
Proxy Solicitation & Information Statement 2026
May 29
Proxy Solicitation & Information Statement 2026
May 29
Regulatory Filings 2026
May 27
Regulatory Filings 2026
May 26
Share Issue/Capital Change 2026
May 22
Regulatory Filings 2026
May 15
Interim / Quarterly Report 2026
May 15
Regulatory Filings 2026
May 15
Regulatory Filings 2026
May 8
View all filings →